1. Clinical Efforts to Combine Endocrine Agents with Targeted Therapies against Epidermal Growth Factor Receptor/Human Epidermal Growth Factor Receptor 2 and Mammalian Target of Rapamycin in Breast Cancer
   Stephen R.D. Johnston, 2006, Clinical Cancer Research CrossRef
2. Nonendocrine Pathways and Endocrine Resistance
   Robert I. Nicholson et al, 2004, Clinical Cancer Research CrossRef
3. Cross-Talk between Estrogen Receptor and Growth Factor Pathways as a Molecular Target for Overcoming Endocrine Resistance
   Rachel Schiff et al, 2004, Clinical Cancer Research CrossRef
4. Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model
   Norman C. Peterson et al, 2005, Carcinogenesis CrossRef
5. Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer
   C.Kent Osborne et al, 2003, The Breast CrossRef
6. Combinations of Endocrine and Biological Agents: Present Status of Therapeutic and Presurgical Investigations
   Stephen RD Johnston, 2005, Clinical Cancer Research CrossRef